20don MSN
Pfizer’s new weight-loss shot: Can one injection a month change obesity treatment as we know it?
With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising effectiveness.
Add Yahoo as a preferred source to see more of our stories on Google. Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years before ...
Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...
Pfizer has reported promising mid-stage trial results for berobenatide, an experimental weight-loss and diabetes medication that could become the world's first once-a-month GLP-1 injection if approved ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results